Empty medicine containers with original labels that are filled with ineffective or harmful substitutes and re-introduced into the market by counterfeiters pose a risk to patients and a challenge to pharmaceutical manufacturers. With the Flexi-Cap security concept Schreiner MediPharm has developed a label-cap combination that protects the integrity of the original containers and helps to prevent their illegal reuse by means of clear, irreversible first-opening indication. At CPhI Worldwide 2019 in Frankfurt from November 5 to 7, Schreiner MediPharm will present Flexi-Cap Prime, the latest version that offers even higher safety.
The special feature of Flexi-Cap Prime is its complex construction with the tear strip running through both the film cap and the label. When the tear strip is opened at the starter tab, it simultaneously destroys the cap and the label so that undetected reuse of the container is no longer possible.
Like all products of the Flexi-Cap family, Flexi-Cap Prime can easily be integrated into the pharmaceutical manufacturer’s production processes. It is also applied without heat, and can be flexibly adapted to diverse container types, shapes and sizes while the label’s design and the pharma manufacturer’s brand appearance remain unchanged. The integration of additional features, such as counterfeiting protection elements, offers further opportunities for securing the supply chain.
For healthcare staff, the newly developed Flexi-Cap Prime is ideal, too: It ensures the integrity of the vial until its final application. Flexi-Cap Prime is easy to use and enables fast and efficient first-opening verification. Thus, patients can beprotected against the administration of ineffective and potentially harmful medications.
Other highlights at Schreiner MediPharm’s booth (Hall 11.1, Booth C45) include Cap-Lock, the novel combination of a tamper-proof cap adapter plus label for syringes, and smart labels with integrated NFC/RFID functionality for a wide range of interactive applications.